These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23775692)

  • 1. PtdIns(4,5)P2-mediated cell signaling: emerging principles and PTEN as a paradigm for regulatory mechanism.
    Gericke A; Leslie NR; Lösche M; Ross AH
    Adv Exp Med Biol; 2013; 991():85-104. PubMed ID: 23775692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
    Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
    J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate.
    Campbell RB; Liu F; Ross AH
    J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT1 and PTEN show the highest affinities among phosphoinositide binding proteins for the second messengers PtdIns(3,4,5)P
    Nelson N; Razeto A; Gilardi A; Grättinger M; Kirchmair J; Jücker M
    Biochem Biophys Res Commun; 2021 Sep; 568():110-115. PubMed ID: 34214875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN and Other PtdIns(3,4,5)P
    Csolle MP; Ooms LM; Papa A; Mitchell CA
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity and acute regulation of the tumour suppressor phosphatase, PTEN.
    Downes CP; Perera N; Ross S; Leslie NR
    Biochem Soc Symp; 2007; (74):69-80. PubMed ID: 17233581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
    Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
    Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN reduces endosomal PtdIns(4,5)P
    Mondin VE; Ben El Kadhi K; Cauvin C; Jackson-Crawford A; Bélanger E; Decelle B; Salomon R; Lowe M; Echard A; Carréno S
    J Cell Biol; 2019 Jul; 218(7):2198-2214. PubMed ID: 31118240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo analysis of 3-phosphoinositide dynamics during Dictyostelium phagocytosis and chemotaxis.
    Dormann D; Weijer G; Dowler S; Weijer CJ
    J Cell Sci; 2004 Dec; 117(Pt 26):6497-509. PubMed ID: 15572406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.
    Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
    Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
    Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live cell imaging with protein domains capable of recognizing phosphatidylinositol 4,5-bisphosphate; a comparative study.
    Szentpetery Z; Balla A; Kim YJ; Lemmon MA; Balla T
    BMC Cell Biol; 2009 Sep; 10():67. PubMed ID: 19769794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis.
    Dove SK; Cooke FT; Douglas MR; Sayers LG; Parker PJ; Michell RH
    Nature; 1997 Nov; 390(6656):187-92. PubMed ID: 9367158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
    Steelman LS; Bertrand FE; McCubrey JA
    Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of PtdIns(4,5)P2--beyond the plasma membrane.
    Tan X; Thapa N; Choi S; Anderson RA
    J Cell Sci; 2015 Nov; 128(22):4047-56. PubMed ID: 26574506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-molecule imaging of PI(4,5)P
    Yoshioka D; Fukushima S; Koteishi H; Okuno D; Ide T; Matsuoka S; Ueda M
    Commun Biol; 2020 Feb; 3(1):92. PubMed ID: 32111929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.